Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

COMPUGROUP MEDICAL SOCIETAS EUROPAEA

(COP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

CompuGroup Medical : Company Presentation June

06/14/2021 | 06:56am EDT

06|2021

IR PRESENTATION

Dr. Dirk Wössner, CEO

Michael Rauch, CFO

Claudia Thomé, CVP IR

Disclaimer

The information provided in this presentation pertaining to CompuGroup Medical SE & Co. KGaA (the "Company"), comprise the written materials/slides for presentations or discussions on the occasion of an investor conference, meeting or conference call ("Meeting"). Whilst all reasonable care has been taken to ensure that the information and facts stated herein as well as oral statements made in the Meeting are accurate and that the opinions and expectations contained herein and orally received during the Meeting are fair and reasonable, no representation or warranty, express or implied, is given by or on behalf of the Company, any of its board members, or any other person as to the accuracy or completeness of the information and/or opinions and no liability as to the accuracy of such information and/or opinions is accepted. The information provided in this presentation as well as during the Meeting contain forward looking statements which involve risks and uncertainties. These forward-looking statements speak only as of the date of the documents and are based on numerous assumptions which may or may not prove to be correct. The actual performance and results of the business of the Company could differ materially from the performance and results discussed in this document or in any other information received during the Meeting. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements or other information contained herein or received during the Meeting whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. Readers are cautioned not to place undue reliance on forward-looking statements or financial projections. The information contained in this presentation and/or received during the Meeting does not constitute or form any part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company, nor shall it or any part of it nor the fact of its distribution form the basis of, or be relied on in connection with, any contract or investment decision in relation thereto.

2

May 2021

IR presentation

CompuGroup Medical - A major beneficiary of digitization in healthcare

Digitization

& Interoperability

along the patient journey

while protecting

medical data and infrastructure

3

May 2021

IR presentation

Servicing the entire healthcare ecosystem, we are ideally positioned for growth

REV SHARE

CUSTOMERS

MARKET POSITIONS

GROWTH

AIS - Ambulatory

Information Systems

45%

Doctors (GPs, specialists), therapists, nurses…

#1

Germany, France,

Austria, Czech Republic,

Sweden, Denmark

#2

Italy, Belgium, Norway

#3

Slovakia, Netherlands

#4

USA

HIS - Hospital

CHS - Consumer &

PCS - Pharmacy

Information Systems

Health Management

Information Systems

22%

19%

14%

Hospitals (acute, post-

All healthcare participants,

Pharmacies

acute), laboratories

pharma & insurance

companies, patients

#2

D-A-CH

#1|2

Frontrunner in

#1

Italy

#2

Spain (public hospitals)

Telematics

#4

Germany

Infrastructure (TI)

#2

Poland

Sweden

#1

DIGITIZATION & REGULATORY INITIATIVES

DRIVERS (mid-term)

Additional modules &

TI: new user groups &

Additional modules &

Rollout of G3 platform

functionalities

Hospital Future Act

modules

functionalities

Patient portals &

(Germany)

Data services

G3 rollout

telemedicine (Clickdoc)

P1 project (Poland)

Patient portals

US synergies & scale effects

4

May 2021

IR presentation

Excellent long-term financial track record

Growth

33%

26%

33%

21%

28%

27%

28%

7%

27%

13%

2%

12%

5%

3%

4%

23%

4%

12%

837

CAGR: 17%

460

515

543

560

582

717

746

293

312

397

451

116

140

180

229

52

69

87

Revenue in €m

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

Margin

31%

26%

36%

34%

27%

28%

21%

20%

21%

19%

23%

21%

19%

21%

22%

22%

26%

27%

26%

CAGR: 16%

105

98

96

112

126

128

188

198

215

67

74

31

40

38

51

49

59

16

18

EBITDA in €m

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

1.95

CAGR: 17%

1.74

1.90

0.22

0.33

0.26

0.46

0.24

0.33

0.62

0.48

0.52

0.77

0.90

0.63

0.12

0.03

0.03

0.19

EPS in €

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

EBITDA and eps adjusted for 2011, 2014, 2018, 2019, 2020.

5

May 2021

IR presentation

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

CompuGroup Medical SE published this content on 14 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2021 10:55:05 UTC.


© Publicnow 2021
All news about COMPUGROUP MEDICAL SOCIETAS EUROPAEA
03:29aCOMPUGROUP MEDICAL : Warburg Research revises his opinion and turns to Neutral
MD
09/15COMPUGROUP MEDICAL : Receives a Sell rating from Baader Bank
MD
09/15COMPUGROUP MEDICAL : Receives a Buy rating from Warburg Research
MD
09/15COMPUGROUP MEDICAL : Gets a Sell rating from Baader Bank
MD
09/14COMPUGROUP MEDICAL : Receives a Buy rating from Jefferies
MD
09/14COMPUGROUP MEDICAL :  Medical announces medium-term targets for EBITDA-margin fo..
PU
09/14COMPUGROUP MEDICAL : announces medium-term targets for EBITDA-margin for the fir..
EQ
09/14PRESS RELEASE : CompuGroup Medical announces medium-term targets for EBITDA-marg..
DJ
09/14CompuGroup Medical SE & Co. KGaA Confirms Earnings Guidance for the Year 2021
CI
09/14CompuGroup Medical SE & Co. KGaA announces medium-term targets for EBITDA-mar..
DJ
More news
Analyst Recommendations on COMPUGROUP MEDICAL SOCIETAS EUROPAEA
More recommendations
Financials
Sales 2021 1 022 M 1 202 M 1 202 M
Net income 2021 81,8 M 96,2 M 96,2 M
Net Debt 2021 486 M 572 M 572 M
P/E ratio 2021 52,7x
Yield 2021 0,71%
Capitalization 4 235 M 4 982 M 4 979 M
EV / Sales 2021 4,62x
EV / Sales 2022 4,31x
Nbr of Employees 8 030
Free-Float 48,8%
Chart COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Duration : Period :
CompuGroup Medical Societas Europaea Technical Analysis Chart | COP | DE0005437305 | MarketScreener
Technical analysis trends COMPUGROUP MEDICAL SOCIETAS EUROPAEA
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 80,30 €
Average target price 84,30 €
Spread / Average Target 4,98%
EPS Revisions
Managers and Directors
Dirk Woessner Chairman-Management Board & CEO
Michael Rauch Chief Financial Officer
Philipp von Ilberg Chairman-Supervisory Board
Frank Brecher Chief Technology Officer
Hannes Reichl Managing Director-Clinical & Social Care
Sector and Competitors
1st jan.Capi. (M$)
COMPUGROUP MEDICAL SOCIETAS EUROPAEA2.16%5 004
ORACLE CORPORATION33.54%240 220
SAP SE13.52%169 674
INTUIT INC.49.60%156 239
SERVICENOW, INC.18.48%129 214
DOCUSIGN, INC.23.10%53 832